Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Full text links

Actions

Share

Review
.2008 Aug;63(8):879-84.
doi: 10.1093/gerona/63.8.879.

ELISA and multiplex technologies for cytokine measurement in inflammation and aging research

Affiliations
Review

ELISA and multiplex technologies for cytokine measurement in inflammation and aging research

Sean X Leng et al. J Gerontol A Biol Sci Med Sci.2008 Aug.

Abstract

Over the last decade there has been an enormous expansion of research focused on defining the role of inflammation in aging, age-related diseases, disability, and frailty. The availability of methods to measure cytokines and other inflammatory mediators or markers with high sensitivity and specificity is critically important. Enzyme-linked immunosorbent assay (ELISA), the most widely used and best validated method, is limited by its ability to measure only a single protein in each sample. Recent developments in serum cytokine quantification technology include multiplex arrays, which offer the potential of better evaluating the complexity and dynamic nature of inflammatory responses and offer substantial cost and sample savings over traditional ELISA measurements. Despite potential advantages of this new technology, experience with these techniques is limited, and it has not emerged to date as the gold standard in inflammatory mediator measurement. This article reviews ELISA and the emerging multiplex technologies, compares the cost and effectiveness of recently developed multiplex arrays with traditional ELISA technology, and provides specific recommendations for investigators interested in measuring serum inflammatory mediators in older adults.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic illustration of the experimental principle for ELISA and bead-based multiplex assays. Both involve capture antibody and detection antibody specific to the cytokine(s) of interest, offering immunological specificity. Enzyme or fluorochrome linked to the detection antibody is the method of detection with signal amplification, offering sensitivity. Panel A illustrates the basic protocol for traditional double antibody sandwich ELISA. Proprietary bead sets provide additional differential detection power in bead-based multiplex arrays (Panel B).
Figure 1
Figure 1
Schematic illustration of the experimental principle for ELISA and bead-based multiplex assays. Both involve capture antibody and detection antibody specific to the cytokine(s) of interest, offering immunological specificity. Enzyme or fluorochrome linked to the detection antibody is the method of detection with signal amplification, offering sensitivity. Panel A illustrates the basic protocol for traditional double antibody sandwich ELISA. Proprietary bead sets provide additional differential detection power in bead-based multiplex arrays (Panel B).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ferrucci L, Ble A, Bandinelli S, et al. A flame burning within. Aging Clin Exp Res. 2004 Jun;16(3):240–243. - PubMed
    1. Ferrucci L, Guralnik JM. Inflammation, hormones, and body composition at a crossroad. Am J Med. 2003 Oct 15;115(6):501–502. - PubMed
    1. Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007 Jan;128(1):92–105. - PubMed
    1. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993 Feb;41(2):176–181. - PubMed
    1. Maggio M, Guralnik JM, Longo DL, et al. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci. 2006 Jun;61(6):575–584. - PMC - PubMed

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp